NeuroMotor Pen, Tool for Early Disease Diagnosis, Soon Widely Available

Manus Neurodynamica, a medical technology company, has raised £750,000 in a financing round to support the rollout of NeuroMotor Pen, a digital pen with a patented sensor technology to help diagnose at early stages movement disorders like Parkinson’s disease. The funding, worth about $950,000, will also be used to develop new technologies with clinical applications. The NeuroMotor Pen combines sensor technologies linked with a software that can record and analyze limb and hand movements.